Partial Responders to Neoadjuvant Therapy and the Risk of Distant Metastases: Longer Intervals to Definitive...

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• The optimal timing for surgical resection following neoadjuvant therapy in rectal cancer is debated.
• Longer intervals post-radiation may improve response rates but raise concerns about distant metastasis in partial responders.

Purpose of the Study:

• To investigate if the time between neoadjuvant chemoradiation therapy completion and surgery impacts distant metastasis development in rectal cancer patients with an excellent partial response.

Main Methods:

• Retrospective cohort study involving 165 rectal cancer patients from three institutions.
• Analysis of patients who achieved near-complete pathological response or clinical complete response with local regrowth.
• Primary outcome assessed was the incidence of distant metastases.

Main Results:

• No significant difference in the time to resection was observed between patients who developed distant metastases and those who did not (9.2 vs. 10.6 months, p=0.55).
• A secondary analysis of patients with local regrowth also found no significant difference in metastasis development based on resection timing (14.4 vs. 17.9 months, p=0.26).

Conclusions:

• The interval between radiation completion and surgical resection does not appear to affect the risk of distant metastases in rectal cancer patients with an excellent partial response.
• Factors beyond the timing of surgery may influence distant metastasis development in this patient subgroup.